期刊文献+

完全控制的支气管哮喘患者186例临床分析 被引量:2

Clinical analysis of 186 patients with totally controlled asthma
下载PDF
导出
摘要 目的探讨获得完全控制的支气管哮喘患者临床特征。方法收集2012年1月至2014年6月深圳市龙岗区人民医院呼吸内科经过规范治疗获得完全控制的支气管哮喘患者186例临床资料与健康对照组进行统计分析。结果完全控制的支气管哮喘患者肺功能指标FEV1%、FEV1/FVC%低于正常对照组,有统计学意义(P<0.01),血清总Ig E及外周血EOS显著高于正常对照组(P<0.01),获得完全控制的支气管哮喘患者不同剂量药物组之间肺功能检查指标FEV1%、FEV1/FVC%无统计学差别(P>0.05)。结论完全控制的支气管哮喘患者肺功能并未恢复正常,仍然存在气道炎症,需要继续抗炎治疗。 Objective To explore the clinical characteristics of patients with totally controlled asthma. Methods 186 patients with totally controlled asthma from January, 2012 to June, 2014 were enrolled in the study and 28 healthy subjects were selected as the control group. Results The forced expiratory volume in one second (FEV1% ) and the forced vital capacity rate of one second (FEV1 / FVC% ) was significant lower in the study group than in the control group (P 〈 0. 01). The serum levels of immunoglobulin E and eosinophil were significant higher in the study group than in the control group (P 〈 0. 01). There was no significant difference in FEV1% and FEV1 /FVC% in patients with controlled asthma treated with different dose drugs (P 〉 0. 05). Conclusion The lung func-tion of patients with totally controlled asthma don′t return to normal, and they still have airway inflammation and need to be given anti-inflammatory treatment.
出处 《临床肺科杂志》 2015年第8期1456-1458,共3页 Journal of Clinical Pulmonary Medicine
关键词 哮喘 完全控制 临床分析 asthma totally controlled clinical analysis
  • 相关文献

参考文献8

二级参考文献25

  • 1孔灵菲.最新全球哮喘防治指南解读[J].中国实用内科杂志,2007,27(4):255-257. 被引量:66
  • 2van den Toorn LM, Overbeer SE,Jongste JC, et al. Airway inflammation is present during clinical remission of atopie asthma. Am J Respir Crit Care Med,2001,164:2107 -2113.
  • 3Global Initative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Revised 2006. Http://www. ginasthma. org.
  • 4Jatakanon A, Lim S, Barnes PG. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med,2000,161 : 64 -72.
  • 5Sont JK, Willems LNA, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med, 1999,159 : 1043 - 1051.
  • 6Cass LM, Gunawardcna KA, Macmahon MM. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Respir Med, 2000,94 : 166 - 173.
  • 7O'Conner GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline in the Normative Aging Study. Am J Respir Crit Care Med, 1995,152:87 - 92.
  • 8Global initiative for asthma (GINA), Global strategy for asthma management and prevention. Revised 2006 [ EB/OL]. http:// www. ginasthma. com ,2006 - 01 - 17/2009 - 07 - 25.
  • 9Eickelberg O, Roth M, Lorx R, et al. Ligand-independent activation of the glucocortcoid receptor by β2-adrenergic receptor agnonists in primary human lung fibroblasts and vascular smooth muscle cells[ J]. J Binl Chem, 1999,274 : 1005.
  • 10Bateman ED,Jacques L, Goldfrad C, et al. Asthma control can be maintained when fluticasone propionate/salmeterol in a single in- haler is stepped down [ J ]. J Allergy Clin Immunol, 2006, 117 : 563 - 570.

共引文献2550

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部